Finance

Lists
HIK:LON
Hikma Pharmaceuticals Plc
GBX 1 602,00
+1,01%
(+16,00) 1D
14 Okt., 16:36:30 GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for HIK...
Open
GBX 1 592,00
High
GBX 1 610,00
Low
GBX 1 569,00
Mkt. cap
3,33 mjd
Avg. vol.
467,91 k
Volume
523,02 k
Dividend
3,96%
Quarterly dividend
GBX 15,85
Ex-dividend date
13 Aug. 2026
P/E ratio
12,09
52-wk high
GBX 1 865,00
52-wk low
GBX 1 187,00
EPS
GBX 1,32
Shares outstanding
208,75 m
No. of employees
10 k
Open
GBX 1 592,00
High
GBX 1 610,00
Low
GBX 1 569,00
Mkt. cap
3,33 mjd
Avg. vol.
467,91 k
Volume
523,02 k
Dividend
3,96%
Quarterly dividend
GBX 15,85
Ex-dividend date
13 Aug. 2026
P/E ratio
12,09
52-wk high
GBX 1 865,00
52-wk low
GBX 1 187,00
EPS
GBX 1,32
Shares outstanding
208,75 m
No. of employees
10 k
News stories
From web sources and news partners
About Hikma Pharmaceuticals Plc
CEO-
Employees9,5 k
Founded1978
HeadquartersLonden, Engeland, Verenigde Koninkryk
SectorPharmaceutical industry
Websitehikma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
845,50 m
845,50 m
864,00 m
864,00 m
Cost of goods sold
479,50 m
479,50 m
477,00 m
477,00 m
Cost of revenue
479,50 m
479,50 m
477,00 m
477,00 m
Research and development expenses
39,00 m
39,00 m
43,00 m
43,00 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
194,00 m
194,00 m
141,00 m
141,00 m
Operating expense
229,00 m
229,00 m
184,00 m
184,00 m
Total operating expenses
708,50 m
708,50 m
661,00 m
661,00 m
Operating income
137,00 m
137,00 m
203,00 m
203,00 m
Other non operating income
-6,00 m
-6,00 m
-
-
EBT including unusual items
112,00 m
112,00 m
143,50 m
143,50 m
EBT excluding unusual items
104,00 m
104,00 m
178,50 m
178,50 m
Income tax expense
28,50 m
28,50 m
31,00 m
31,00 m
Effective tax rate
25,45%
25,45%
21,60%
21,60%
Other operating expenses
-4,00 m
-4,00 m
-
-
Net income
82,00 m
82,00 m
111,50 m
111,50 m
Net profit margin
9,70%
9,70%
12,90%
12,90%
Earnings per share
-
-
-
-
Interest and investment income
1,00 m
1,00 m
1,50 m
1,50 m
Interest expense
-22,50 m
-22,50 m
-26,00 m
-26,00 m
Net interest expenses
-21,50 m
-21,50 m
-24,50 m
-24,50 m
Depreciation and amortization charges
-
-
-
-
EBITDA
183,00 m
183,00 m
250,50 m
250,50 m
Gain or loss from assets sale
500,00 k
500,00 k
-
-
AI content may include mistakes. Learn more
Google-programme